Retatrutide

DB18993InvestigationalProtein Based Therapies

Retatrutide is under investigation in clinical trial NCT06354660 (Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone...

Mechanism: Pharmacologically active on Glucagon receptor, Glucagon-like peptide 1 receptor, and Gastric inhibitory polypeptide receptor
Curator reviewed
Code names: LY-3437943

Resolves to

Compound

UNIINOP2Y096GVCAS2381089-83-2

Clinical / RWD

RxNorm2722410

Targets

P47871GCGRP43220GLP1RP48546GIPR

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

25Clinical trialsPhase, status and sponsor resolved per trial

10Marketed productsAcross 1 country and 1 labeller

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Retatrutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account